Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-20
1994-06-07
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514159, 514161, A61K 3140
Patent
active
053189850
ABSTRACT:
The present invention is directed to a method for poteniating the therapeutic effects of selected NMDA antagonists.
REFERENCES:
patent: 2608507 (1952-08-01), Miller
patent: 4960786 (1990-10-01), Salituro et al.
patent: 5051442 (1991-09-01), Salituro et al.
patent: 5106847 (1992-04-01), Salituro et al.
Brain Research Bulletin, vol. 28, pp. 244-238, Vecsei, et al.
Baron Bruce M.
McDonald Ian A.
Dixon J. Michael
Merrell Dow Pharmaceuticals Inc.
Waddell Frederick E.
Weddington K.
LandOfFree
Potentiation of NMDA antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Potentiation of NMDA antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Potentiation of NMDA antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-792896